Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesActive in the last 2 years

Keke Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0007-6326; OpenAlex author ID A5038792983. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 8

  1. The prognostic value of myosteatosis in pancreatic cancer: A systematic review and meta-analysis. Last author DOI 10.1016/j.clnu.2024.10.017↗
  2. Artificial intelligence to predict T4 stage of pancreatic ductal adenocarcinoma using CT imaging. Last author DOI 10.1016/j.compbiomed.2024.108125↗
  3. MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling. First author DOI 10.1158/1078-0432.ccr-22-3322↗
  4. Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells. Co-author DOI 10.1016/j.celrep.2021.110236↗
  5. NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition. Co-author DOI 10.1073/pnas.2012469118↗
  6. Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach. Co-author DOI 10.1186/s12885-020-6522-3↗
  7. The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways. Co-author DOI 10.2147/ott.s248507↗
  8. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer. Co-author DOI 10.2217/epi-2019-0374↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaodong Tan · 4 shared papers, 2020–2024 · strength 0.56
  2. Qi Miao · 2 shared papers, 2024 · strength 0.43
  3. Lingming Kong · 3 shared papers, 2020 · strength 0.38
  4. Peng Liu · 3 shared papers, 2020 · strength 0.38
  5. Timothy R. Donahue · 3 shared papers, 2021–2023 · strength 0.36
  6. Evan R. Abt · 3 shared papers, 2021–2023 · strength 0.36
  7. Caius Gabriel Radu · 3 shared papers, 2021–2023 · strength 0.36
  8. Jason M. Link · 2 shared papers, 2022–2023 · strength 0.26
  9. Razmik Ghukasyan · 2 shared papers, 2021–2023 · strength 0.25
  10. Hongbo Chen · 1 shared paper, 2024 · strength 0.24
  11. Jing Cui · 2 shared papers, 2021–2022 · strength 0.21
  12. David W. Dawson · 2 shared papers, 2021–2022 · strength 0.21
  13. Joon Y. Park · 1 shared paper, 2023 · strength 0.15
  14. Haoyi Jin · 1 shared paper, 2020 · strength 0.13
  15. Bing Song · 1 shared paper, 2020 · strength 0.13
  16. Yunhao Wu · 1 shared paper, 2020 · strength 0.13
  17. Yang Gao · 1 shared paper, 2020 · strength 0.12
  18. Johannes Czernin · 1 shared paper, 2022 · strength 0.11
  19. Irmina A. Elliott · 1 shared paper, 2021 · strength 0.10
  20. Alexandra M. Moore · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.